#1Regional leaders 1–100
Roche
Switzerland · Switzerland
Diversified pharmaFinished dosage forms and small molecules
Open article →FUZKK EUROPE & ISRAEL TOP 300
EU + Switzerland + United Kingdom + Israel: Top 300 pharma manufacturers
The atlas combines the 27 EU Member States, Switzerland, the United Kingdom and Israel. Positions 1–100 represent the regional leaders of the FUZKK atlas; positions 101–300 extend coverage across generics, biopharma, API/CDMO and specialist manufacturers.
300companies
100Regional leaders 1–100
200FUZKK selection 101–300
30countries
The Top 300 is a FUZKK atlas priority rather than a single official revenue table. The mapping does not claim actual use of FUZKK, a specific installed equipment model or a product not confirmed by the public company profile.
#2Regional leaders 1–100
Novartis
Switzerland · Switzerland
Diversified pharmaRadiopharmaceuticalsFinished dosage forms and small molecules
Open article →#3Regional leaders 1–100
Novo Nordisk
Denmark · European Union
Peptides and complex injectablesFinished dosage forms and small molecules
Open article →#4Regional leaders 1–100
AstraZeneca
United Kingdom · United Kingdom
Diversified pharmaInhalation productsFinished dosage forms and small molecules
Open article →#5Regional leaders 1–100
Sanofi
France · European Union
Diversified pharmaFinished dosage forms and small molecules
Open article →#6Regional leaders 1–100
GSK
United Kingdom · United Kingdom
Diversified pharmaInhalation productsFinished dosage forms and small molecules
Open article →#7Regional leaders 1–100
Bayer
Germany · European Union
Diversified pharmaFinished dosage forms and small molecules
Open article →#8Regional leaders 1–100
Boehringer Ingelheim
Germany · European Union
Diversified pharmaFinished dosage forms and small molecules
Open article →#9Regional leaders 1–100
Merck KGaA
Germany · European Union
Diversified pharmaFinished dosage forms and small molecules
Open article →#10Regional leaders 1–100
UCB
Belgium · European Union
Diversified pharmaFinished dosage forms and small molecules
Open article →#11Regional leaders 1–100
Sandoz
Switzerland · Switzerland
Diversified pharmaFinished dosage forms and small molecules
Open article →#12Regional leaders 1–100
Fresenius Kabi
Germany · European Union
Sterile and injectable productsFinished dosage forms and small molecules
Open article →#13Regional leaders 1–100
Teva Pharmaceutical Industries
Israel · Israel
Diversified pharmaFinished dosage forms and small molecules
Open article →#14Regional leaders 1–100
Lonza
Switzerland · Switzerland
API / CDMO / manufacturing
Open article →#15Regional leaders 1–100
CSL Vifor
Switzerland · Switzerland
Plasma, heparin and protein productsFinished dosage forms and small molecules
Open article →#16Regional leaders 1–100
Chiesi Farmaceutici
Italy · European Union
Inhalation productsFinished dosage forms and small molecules
Open article →#17Regional leaders 1–100
Menarini
Italy · European Union
Diversified pharmaOncology / ADC / high-potencyFinished dosage forms and small molecules
Open article →#18Regional leaders 1–100
Servier
France · European Union
Diversified pharmaOncology / ADC / high-potencyFinished dosage forms and small molecules
Open article →#19Regional leaders 1–100
Ipsen
France · European Union
Peptides and complex injectablesOncology / ADC / high-potencyFinished dosage forms and small molecules
Open article →#20Regional leaders 1–100
Recordati
Italy · European Union
Diversified pharmaFinished dosage forms and small molecules
Open article →#21Regional leaders 1–100
Hikma Pharmaceuticals
United Kingdom · United Kingdom
Sterile and injectable productsFinished dosage forms and small molecules
Open article →#22Regional leaders 1–100
Grifols
Spain · European Union
Vaccines and plasma productsPlasma, heparin and protein productsFinished dosage forms and small molecules
Open article →#23Regional leaders 1–100
Lundbeck
Denmark · European Union
Finished dosage forms and small molecules
Open article →#24Regional leaders 1–100
LEO Pharma
Denmark · European Union
Finished dosage forms and small molecules
Open article →#25Regional leaders 1–100
ALK-Abelló
Denmark · European Union
Finished dosage forms and small molecules
Open article →#26Regional leaders 1–100
Genmab
Denmark · European Union
BiologicsFinished dosage forms and small molecules
Open article →#27Regional leaders 1–100
Bavarian Nordic
Denmark · European Union
Vaccines and plasma productsFinished dosage forms and small molecules
Open article →#28Regional leaders 1–100
Swedish Orphan Biovitrum
Sweden · European Union
BiologicsFinished dosage forms and small molecules
Open article →#29Regional leaders 1–100
Recipharm
Sweden · European Union
API / CDMO / manufacturing
Open article →#30Regional leaders 1–100
Ferring Pharmaceuticals
Switzerland · Switzerland
Finished dosage forms and small molecules
Open article →#31Regional leaders 1–100
Octapharma
Switzerland · Switzerland
Vaccines and plasma productsPlasma, heparin and protein productsFinished dosage forms and small molecules
Open article →#32Regional leaders 1–100
Bachem
Switzerland · Switzerland
API / CDMO / manufacturingPeptides and complex injectables
Open article →#33Regional leaders 1–100
Siegfried
Switzerland · Switzerland
API / CDMO / manufacturing
Open article →#34Regional leaders 1–100
Gedeon Richter
Hungary · European Union
Diversified pharmaFinished dosage forms and small molecules
Open article →#35Regional leaders 1–100
STADA
Germany · European Union
Diversified pharmaFinished dosage forms and small molecules
Open article →#36Regional leaders 1–100
BioNTech
Germany · European Union
BiologicsFinished dosage forms and small molecules
Open article →#37Regional leaders 1–100
CureVac
Germany · European Union
BiologicsFinished dosage forms and small molecules
Open article →#38Regional leaders 1–100
Grünenthal
Germany · European Union
Finished dosage forms and small molecules
Open article →#39Regional leaders 1–100
Vetter Pharma
Germany · European Union
API / CDMO / manufacturing
Open article →#40Regional leaders 1–100
Rentschler Biopharma
Germany · European Union
API / CDMO / manufacturing
Open article →#41Regional leaders 1–100
IDT Biologika
Germany · European Union
BiologicsFinished dosage forms and small molecules
Open article →#42Regional leaders 1–100
Aenova Group
Germany · European Union
API / CDMO / manufacturing
Open article →#43Regional leaders 1–100
B. Braun
Germany · European Union
Sterile and injectable productsMedical Devices / drug delivery
Open article →#44Regional leaders 1–100
Pierre Fabre
France · European Union
Diversified pharmaFinished dosage forms and small molecules
Open article →#45Regional leaders 1–100
LFB
France · European Union
Vaccines and plasma productsFinished dosage forms and small molecules
Open article →#46Regional leaders 1–100
Seqens
France · European Union
API / CDMO / manufacturing
Open article →#47Regional leaders 1–100
EuroAPI
France · European Union
API / CDMO / manufacturing
Open article →#48Regional leaders 1–100
Guerbet
France · European Union
Diagnostics and contrast mediaFinished dosage forms and small molecules
Open article →#49Regional leaders 1–100
bioMérieux
France · European Union
Diagnostics and contrast mediaFinished dosage forms and small molecules
Open article →#50Regional leaders 1–100
Valneva
France · European Union
Vaccines and plasma productsFinished dosage forms and small molecules
Open article →#51Regional leaders 1–100
Kedrion Biopharma
Italy · European Union
Vaccines and plasma productsPlasma, heparin and protein productsFinished dosage forms and small molecules
Open article →#52Regional leaders 1–100
Bracco
Italy · European Union
Diagnostics and contrast mediaFinished dosage forms and small molecules
Open article →#53Regional leaders 1–100
Alfasigma
Italy · European Union
Diversified pharmaFinished dosage forms and small molecules
Open article →#54Regional leaders 1–100
Italfarmaco
Italy · European Union
Diversified pharmaFinished dosage forms and small molecules
Open article →#55Regional leaders 1–100
Angelini Pharma
Italy · European Union
Diversified pharmaFinished dosage forms and small molecules
Open article →#56Regional leaders 1–100
Dompé
Italy · European Union
Oncology / ADC / high-potencyFinished dosage forms and small molecules
Open article →#57Regional leaders 1–100
Zambon
Italy · European Union
Diversified pharmaFinished dosage forms and small molecules
Open article →#58Regional leaders 1–100
Almirall
Spain · European Union
Finished dosage forms and small molecules
Open article →#59Regional leaders 1–100
Esteve
Spain · European Union
Finished dosage forms and small molecules
Open article →#60Regional leaders 1–100
Ferrer
Spain · European Union
Finished dosage forms and small molecules
Open article →#61Regional leaders 1–100
PharmaMar
Spain · European Union
Oncology / ADC / high-potencyFinished dosage forms and small molecules
Open article →#62Regional leaders 1–100
Laboratorios Rovi
Spain · European Union
Sterile and injectable productsFinished dosage forms and small molecules
Open article →#63Regional leaders 1–100
HIPRA
Spain · European Union
Vaccines and plasma productsFinished dosage forms and small molecules
Open article →#64Regional leaders 1–100
Polpharma
Poland · European Union
Diversified pharmaFinished dosage forms and small molecules
Open article →#65Regional leaders 1–100
Adamed Pharma
Poland · European Union
Finished dosage forms and small molecules
Open article →#66Regional leaders 1–100
KRKA
Slovenia · European Union
Diversified pharmaFinished dosage forms and small molecules
Open article →#67Regional leaders 1–100
Zentiva
Czechia · European Union
Diversified pharmaFinished dosage forms and small molecules
Open article →#68Regional leaders 1–100
Egis Pharmaceuticals
Hungary · European Union
Finished dosage forms and small molecules
Open article →#69Regional leaders 1–100
DEMO Pharmaceuticals
Greece · European Union
Sterile and injectable productsFinished dosage forms and small molecules
Open article →#70Regional leaders 1–100
Pharmathen
Greece · European Union
Sterile and injectable productsFinished dosage forms and small molecules
Open article →#71Regional leaders 1–100
BIAL
Portugal · European Union
Finished dosage forms and small molecules
Open article →#72Regional leaders 1–100
Hovione
Portugal · European Union
API / CDMO / manufacturing
Open article →#73Regional leaders 1–100
Orion
Finland · European Union
Inhalation productsFinished dosage forms and small molecules
Open article →#74Regional leaders 1–100
Accord Healthcare
United Kingdom · United Kingdom
Finished dosage forms and small molecules
Open article →#75Regional leaders 1–100
ADVANZ Pharma
United Kingdom · United Kingdom
Finished dosage forms and small molecules
Open article →#76Regional leaders 1–100
Norgine
United Kingdom · United Kingdom
Finished dosage forms and small molecules
Open article →#77Regional leaders 1–100
Indivior
United Kingdom · United Kingdom
Finished dosage forms and small molecules
Open article →#78Regional leaders 1–100
Dechra Pharmaceuticals
United Kingdom · United Kingdom
Veterinary pharmaFinished dosage forms and small molecules
Open article →#79Regional leaders 1–100
Oxford Biomedica
United Kingdom · United Kingdom
Cell and gene therapyFinished dosage forms and small molecules
Open article →#80Regional leaders 1–100
Immunocore
United Kingdom · United Kingdom
Cell and gene therapyFinished dosage forms and small molecules
Open article →#81Regional leaders 1–100
Autolus Therapeutics
United Kingdom · United Kingdom
Cell and gene therapyFinished dosage forms and small molecules
Open article →#82Regional leaders 1–100
Organon
Netherlands · European Union
Diversified pharmaFinished dosage forms and small molecules
Open article →#83Regional leaders 1–100
Synthon
Netherlands · European Union
Finished dosage forms and small molecules
Open article →#84Regional leaders 1–100
Pharming Group
Netherlands · European Union
BiologicsFinished dosage forms and small molecules
Open article →#85Regional leaders 1–100
Jazz Pharmaceuticals
Ireland · European Union
Oncology / ADC / high-potencyFinished dosage forms and small molecules
Open article →#86Regional leaders 1–100
Alkermes
Ireland · European Union
Finished dosage forms and small molecules
Open article →#87Regional leaders 1–100
Perrigo
Ireland · European Union
Consumer healthFinished dosage forms and small molecules
Open article →#88Regional leaders 1–100
Janssen Pharmaceutica
Belgium · European Union
Finished dosage forms and small molecules
Open article →#89Regional leaders 1–100
argenx
Belgium · European Union
BiologicsFinished dosage forms and small molecules
Open article →#90Regional leaders 1–100
Galapagos
Belgium · European Union
BiologicsFinished dosage forms and small molecules
Open article →#91Regional leaders 1–100
Kamada
Israel · Israel
BiologicsVaccines and plasma productsPlasma, heparin and protein products
Open article →#92Regional leaders 1–100
Protalix BioTherapeutics
Israel · Israel
BiologicsFinished dosage forms and small molecules
Open article →#93Regional leaders 1–100
MediWound
Israel · Israel
BiologicsFinished dosage forms and small molecules
Open article →#94Regional leaders 1–100
BioLineRx
Israel · Israel
Oncology / ADC / high-potencyFinished dosage forms and small molecules
Open article →#95Regional leaders 1–100
AOP Health
Austria · European Union
Sterile and injectable productsFinished dosage forms and small molecules
Open article →#96Regional leaders 1–100
Pharmacosmos
Denmark · European Union
Peptides and complex injectablesFinished dosage forms and small molecules
Open article →#97Regional leaders 1–100
Xellia Pharmaceuticals
Denmark · European Union
Sterile and injectable productsAntibiotics and fermentationFinished dosage forms and small molecules
Open article →#98Regional leaders 1–100
Ascendis Pharma
Denmark · European Union
Peptides and complex injectablesFinished dosage forms and small molecules
Open article →#99Regional leaders 1–100
Zealand Pharma
Denmark · European Union
Peptides and complex injectablesFinished dosage forms and small molecules
Open article →#100Regional leaders 1–100
Formycon
Germany · European Union
BiologicsFinished dosage forms and small molecules
Open article →#101FUZKK selection 101–300
Dermapharm
Germany · European Union
Finished dosage forms and small molecules
Open article →#102FUZKK selection 101–300
Evotec
Germany · European Union
Finished dosage forms and small molecules
Open article →#103FUZKK selection 101–300
Biotest
Germany · European Union
BiologicsVaccines and plasma productsFinished dosage forms and small molecules
Open article →#104FUZKK selection 101–300
MEDICE
Germany · European Union
Finished dosage forms and small molecules
Open article →#105FUZKK selection 101–300
Wacker Biotech
Germany · European Union
API / CDMO / manufacturing
Open article →#106FUZKK selection 101–300
Miltenyi Biotec
Germany · European Union
BiologicsMedical Devices / drug delivery
Open article →#107FUZKK selection 101–300
Dr. Falk Pharma
Germany · European Union
Finished dosage forms and small molecules
Open article →#108FUZKK selection 101–300
Schwabe Pharmaceuticals
Germany · European Union
Consumer healthFinished dosage forms and small molecules
Open article →#109FUZKK selection 101–300
Aristo Pharma
Germany · European Union
Finished dosage forms and small molecules
Open article →#110FUZKK selection 101–300
Berlin-Chemie
Germany · European Union
Finished dosage forms and small molecules
Open article →#111FUZKK selection 101–300
ITM Isotope Technologies Munich
Germany · European Union
RadiopharmaceuticalsFinished dosage forms and small molecules
Open article →#112FUZKK selection 101–300
Eckert & Ziegler
Germany · European Union
RadiopharmaceuticalsFinished dosage forms and small molecules
Open article →#113FUZKK selection 101–300
Engelhard Arzneimittel
Germany · European Union
Consumer healthFinished dosage forms and small molecules
Open article →#114FUZKK selection 101–300
Ursapharm
Germany · European Union
OphthalmicsFinished dosage forms and small molecules
Open article →#115FUZKK selection 101–300
medac
Germany · European Union
Finished dosage forms and small molecules
Open article →#116FUZKK selection 101–300
Heel
Germany · European Union
Consumer healthFinished dosage forms and small molecules
Open article →#117FUZKK selection 101–300
Fareva
France · European Union
API / CDMO / manufacturing
Open article →#118FUZKK selection 101–300
Delpharm
France · European Union
API / CDMO / manufacturing
Open article →#119FUZKK selection 101–300
Virbac
France · European Union
Veterinary pharmaFinished dosage forms and small molecules
Open article →#120FUZKK selection 101–300
Inventiva
France · European Union
Finished dosage forms and small molecules
Open article →#121FUZKK selection 101–300
MaaT Pharma
France · European Union
Finished dosage forms and small molecules
Open article →#122FUZKK selection 101–300
Nanobiotix
France · European Union
Oncology / ADC / high-potencyFinished dosage forms and small molecules
Open article →#123FUZKK selection 101–300
Cellectis
France · European Union
Cell and gene therapyOncology / ADC / high-potencyFinished dosage forms and small molecules
Open article →#124FUZKK selection 101–300
DBV Technologies
France · European Union
Finished dosage forms and small molecules
Open article →#125FUZKK selection 101–300
Innate Pharma
France · European Union
BiologicsFinished dosage forms and small molecules
Open article →#126FUZKK selection 101–300
Curium Pharma
France · European Union
RadiopharmaceuticalsFinished dosage forms and small molecules
Open article →#127FUZKK selection 101–300
Oncodesign Precision Medicine
France · European Union
Oncology / ADC / high-potencyFinished dosage forms and small molecules
Open article →#128FUZKK selection 101–300
Abivax
France · European Union
Finished dosage forms and small molecules
Open article →#129FUZKK selection 101–300
Adocia
France · European Union
Peptides and complex injectablesFinished dosage forms and small molecules
Open article →#130FUZKK selection 101–300
Genfit
France · European Union
BiologicsFinished dosage forms and small molecules
Open article →#131FUZKK selection 101–300
OSE Immunotherapeutics
France · European Union
BiologicsFinished dosage forms and small molecules
Open article →#132FUZKK selection 101–300
Fidia Farmaceutici
Italy · European Union
OphthalmicsFinished dosage forms and small molecules
Open article →#133FUZKK selection 101–300
Abiogen Pharma
Italy · European Union
BiologicsFinished dosage forms and small molecules
Open article →#134FUZKK selection 101–300
Molteni Farmaceutici
Italy · European Union
Finished dosage forms and small molecules
Open article →#135FUZKK selection 101–300
PharmaNutra
Italy · European Union
Consumer healthFinished dosage forms and small molecules
Open article →#136FUZKK selection 101–300
SIFI
Italy · European Union
OphthalmicsFinished dosage forms and small molecules
Open article →#137FUZKK selection 101–300
Olon
Italy · European Union
API / CDMO / manufacturing
Open article →#138FUZKK selection 101–300
Fabbrica Italiana Sintetici
Italy · European Union
API / CDMO / manufacturing
Open article →#139FUZKK selection 101–300
Dipharma Francis
Italy · European Union
API / CDMO / manufacturing
Open article →#140FUZKK selection 101–300
Fine Foods & Pharmaceuticals NTM
Italy · European Union
API / CDMO / manufacturing
Open article →#141FUZKK selection 101–300
ACS Dobfar
Italy · European Union
API / CDMO / manufacturing
Open article →#142FUZKK selection 101–300
Industriale Chimica
Italy · European Union
API / CDMO / manufacturing
Open article →#143FUZKK selection 101–300
Neopharmed Gentili
Italy · European Union
BiologicsFinished dosage forms and small molecules
Open article →#144FUZKK selection 101–300
SOFAR
Italy · European Union
Finished dosage forms and small molecules
Open article →#145FUZKK selection 101–300
Reig Jofre
Spain · European Union
Sterile and injectable productsFinished dosage forms and small molecules
Open article →#146FUZKK selection 101–300
Faes Farma
Spain · European Union
Finished dosage forms and small molecules
Open article →#147FUZKK selection 101–300
Cinfa
Spain · European Union
Finished dosage forms and small molecules
Open article →#148FUZKK selection 101–300
Laboratorios Normon
Spain · European Union
Finished dosage forms and small molecules
Open article →#149FUZKK selection 101–300
Insud Pharma
Spain · European Union
API / CDMO / manufacturing
Open article →#150FUZKK selection 101–300
mAbxience
Spain · European Union
API / CDMO / manufacturing
Open article →#151FUZKK selection 101–300
Medichem
Spain · European Union
API / CDMO / manufacturing
Open article →#152FUZKK selection 101–300
Kern Pharma
Spain · European Union
Finished dosage forms and small molecules
Open article →#153FUZKK selection 101–300
Laboratorios Salvat
Spain · European Union
OphthalmicsFinished dosage forms and small molecules
Open article →#154FUZKK selection 101–300
Cantabria Labs
Spain · European Union
Consumer healthFinished dosage forms and small molecules
Open article →#155FUZKK selection 101–300
Neuraxpharm
Spain · European Union
Finished dosage forms and small molecules
Open article →#156FUZKK selection 101–300
Acino
Switzerland · Switzerland
Finished dosage forms and small molecules
Open article →#157FUZKK selection 101–300
Idorsia
Switzerland · Switzerland
Finished dosage forms and small molecules
Open article →#158FUZKK selection 101–300
Basilea Pharmaceutica
Switzerland · Switzerland
BiologicsFinished dosage forms and small molecules
Open article →#159FUZKK selection 101–300
PolyPeptide Group
Switzerland · Switzerland
API / CDMO / manufacturingPeptides and complex injectables
Open article →#160FUZKK selection 101–300
IBSA
Switzerland · Switzerland
Finished dosage forms and small molecules
Open article →#161FUZKK selection 101–300
Debiopharm
Switzerland · Switzerland
BiologicsFinished dosage forms and small molecules
Open article →#162FUZKK selection 101–300
ADC Therapeutics
Switzerland · Switzerland
Oncology / ADC / high-potencyFinished dosage forms and small molecules
Open article →#163FUZKK selection 101–300
CRISPR Therapeutics
Switzerland · Switzerland
Cell and gene therapyFinished dosage forms and small molecules
Open article →#164FUZKK selection 101–300
Helsinn
Switzerland · Switzerland
Finished dosage forms and small molecules
Open article →#165FUZKK selection 101–300
Haleon
United Kingdom · United Kingdom
Consumer healthFinished dosage forms and small molecules
Open article →#166FUZKK selection 101–300
Orchard Therapeutics
United Kingdom · United Kingdom
Cell and gene therapyFinished dosage forms and small molecules
Open article →#167FUZKK selection 101–300
Mereo BioPharma
United Kingdom · United Kingdom
Oncology / ADC / high-potencyFinished dosage forms and small molecules
Open article →#168FUZKK selection 101–300
Verona Pharma
United Kingdom · United Kingdom
Inhalation productsFinished dosage forms and small molecules
Open article →#169FUZKK selection 101–300
Shield Therapeutics
United Kingdom · United Kingdom
BiologicsFinished dosage forms and small molecules
Open article →#170FUZKK selection 101–300
Silence Therapeutics
United Kingdom · United Kingdom
BiologicsFinished dosage forms and small molecules
Open article →#171FUZKK selection 101–300
Bicycle Therapeutics
United Kingdom · United Kingdom
Oncology / ADC / high-potencyFinished dosage forms and small molecules
Open article →#172FUZKK selection 101–300
Futura Medical
United Kingdom · United Kingdom
Medical Devices / drug delivery
Open article →#173FUZKK selection 101–300
Allergy Therapeutics
United Kingdom · United Kingdom
BiologicsFinished dosage forms and small molecules
Open article →#174FUZKK selection 101–300
Vectura
United Kingdom · United Kingdom
Inhalation productsFinished dosage forms and small molecules
Open article →#175FUZKK selection 101–300
Mundipharma
United Kingdom · United Kingdom
Inhalation productsFinished dosage forms and small molecules
Open article →#176FUZKK selection 101–300
Rosemont Pharmaceuticals
United Kingdom · United Kingdom
Finished dosage forms and small molecules
Open article →#177FUZKK selection 101–300
Kent Pharma
United Kingdom · United Kingdom
Finished dosage forms and small molecules
Open article →#178FUZKK selection 101–300
Colonis Pharma
United Kingdom · United Kingdom
Finished dosage forms and small molecules
Open article →#179FUZKK selection 101–300
Arecor Therapeutics
United Kingdom · United Kingdom
Medical Devices / drug delivery
Open article →#180FUZKK selection 101–300
Compugen
Israel · Israel
BiologicsFinished dosage forms and small molecules
Open article →#181FUZKK selection 101–300
RedHill Biopharma
Israel · Israel
BiologicsFinished dosage forms and small molecules
Open article →#182FUZKK selection 101–300
Dexcel Pharma
Israel · Israel
Finished dosage forms and small molecules
Open article →#183FUZKK selection 101–300
Rafa Laboratories
Israel · Israel
Finished dosage forms and small molecules
Open article →#184FUZKK selection 101–300
Rekah Pharmaceutical Industry
Israel · Israel
Finished dosage forms and small molecules
Open article →#185FUZKK selection 101–300
Unipharm Israel
Israel · Israel
Finished dosage forms and small molecules
Open article →#186FUZKK selection 101–300
Trima
Israel · Israel
Finished dosage forms and small molecules
Open article →#187FUZKK selection 101–300
Padagis Israel
Israel · Israel
Finished dosage forms and small molecules
Open article →#188FUZKK selection 101–300
Pluri
Israel · Israel
Cell and gene therapyFinished dosage forms and small molecules
Open article →#189FUZKK selection 101–300
Enlivex Therapeutics
Israel · Israel
Cell and gene therapyFinished dosage forms and small molecules
Open article →#190FUZKK selection 101–300
PolyPid
Israel · Israel
Finished dosage forms and small molecules
Open article →#191FUZKK selection 101–300
Can-Fite BioPharma
Israel · Israel
Oncology / ADC / high-potencyFinished dosage forms and small molecules
Open article →#192FUZKK selection 101–300
Purple Biotech
Israel · Israel
Oncology / ADC / high-potencyFinished dosage forms and small molecules
Open article →#193FUZKK selection 101–300
AJ Vaccines
Denmark · European Union
Vaccines and plasma productsFinished dosage forms and small molecules
Open article →#194FUZKK selection 101–300
Symphogen
Denmark · European Union
BiologicsFinished dosage forms and small molecules
Open article →#195FUZKK selection 101–300
Orexo
Sweden · European Union
Finished dosage forms and small molecules
Open article →#196FUZKK selection 101–300
Camurus
Sweden · European Union
Finished dosage forms and small molecules
Open article →#197FUZKK selection 101–300
BioArctic
Sweden · European Union
BiologicsFinished dosage forms and small molecules
Open article →#198FUZKK selection 101–300
Hansa Biopharma
Sweden · European Union
BiologicsFinished dosage forms and small molecules
Open article →#199FUZKK selection 101–300
Egetis Therapeutics
Sweden · European Union
BiologicsFinished dosage forms and small molecules
Open article →#200FUZKK selection 101–300
Oncopeptides
Sweden · European Union
BiologicsOncology / ADC / high-potencyFinished dosage forms and small molecules
Open article →#201FUZKK selection 101–300
Vicore Pharma
Sweden · European Union
BiologicsFinished dosage forms and small molecules
Open article →#202FUZKK selection 101–300
Xbrane Biopharma
Sweden · European Union
BiologicsFinished dosage forms and small molecules
Open article →#203FUZKK selection 101–300
BioInvent
Sweden · European Union
BiologicsFinished dosage forms and small molecules
Open article →#204FUZKK selection 101–300
Calliditas Therapeutics
Sweden · European Union
BiologicsFinished dosage forms and small molecules
Open article →#205FUZKK selection 101–300
Hyloris Pharmaceuticals
Belgium · European Union
Finished dosage forms and small molecules
Open article →#206FUZKK selection 101–300
Univercells
Belgium · European Union
API / CDMO / manufacturing
Open article →#207FUZKK selection 101–300
Ajinomoto Bio-Pharma Services Belgium
Belgium · European Union
API / CDMO / manufacturing
Open article →#208FUZKK selection 101–300
Celyad Oncology
Belgium · European Union
Cell and gene therapyFinished dosage forms and small molecules
Open article →#209FUZKK selection 101–300
BioSenic
Belgium · European Union
BiologicsFinished dosage forms and small molecules
Open article →#210FUZKK selection 101–300
eTheRNA immunotherapies
Belgium · European Union
Cell and gene therapyFinished dosage forms and small molecules
Open article →#211FUZKK selection 101–300
uniQure
Netherlands · European Union
Cell and gene therapyFinished dosage forms and small molecules
Open article →#212FUZKK selection 101–300
ProQR Therapeutics
Netherlands · European Union
Cell and gene therapyFinished dosage forms and small molecules
Open article →#213FUZKK selection 101–300
HALIX
Netherlands · European Union
API / CDMO / manufacturing
Open article →#214FUZKK selection 101–300
Byondis
Netherlands · European Union
Finished dosage forms and small molecules
Open article →#215FUZKK selection 101–300
Centrient Pharmaceuticals
Netherlands · European Union
Finished dosage forms and small molecules
Open article →#216FUZKK selection 101–300
AM-Pharma
Netherlands · European Union
Finished dosage forms and small molecules
Open article →#217FUZKK selection 101–300
Leyden Labs
Netherlands · European Union
Finished dosage forms and small molecules
Open article →#218FUZKK selection 101–300
VarmX
Netherlands · European Union
Finished dosage forms and small molecules
Open article →#219FUZKK selection 101–300
Batavia Biosciences
Netherlands · European Union
API / CDMO / manufacturing
Open article →#220FUZKK selection 101–300
Mallinckrodt Pharmaceuticals
Ireland · European Union
Finished dosage forms and small molecules
Open article →#221FUZKK selection 101–300
Chanelle Pharma
Ireland · European Union
Veterinary pharmaFinished dosage forms and small molecules
Open article →#222FUZKK selection 101–300
Amarin
Ireland · European Union
Finished dosage forms and small molecules
Open article →#223FUZKK selection 101–300
Shorla Oncology
Ireland · European Union
Oncology / ADC / high-potencyFinished dosage forms and small molecules
Open article →#224FUZKK selection 101–300
Poolbeg Pharma
Ireland · European Union
Finished dosage forms and small molecules
Open article →#225FUZKK selection 101–300
Polpharma Biologics
Poland · European Union
BiologicsFinished dosage forms and small molecules
Open article →#226FUZKK selection 101–300
Celon Pharma
Poland · European Union
Oncology / ADC / high-potencyFinished dosage forms and small molecules
Open article →#227FUZKK selection 101–300
Mabion
Poland · European Union
BiologicsFinished dosage forms and small molecules
Open article →#228FUZKK selection 101–300
Bioton
Poland · European Union
BiologicsFinished dosage forms and small molecules
Open article →#229FUZKK selection 101–300
Polfa Tarchomin
Poland · European Union
Antibiotics and fermentationFinished dosage forms and small molecules
Open article →#230FUZKK selection 101–300
TZF Polfa
Poland · European Union
Antibiotics and fermentationFinished dosage forms and small molecules
Open article →#231FUZKK selection 101–300
Hasco-Lek
Poland · European Union
Finished dosage forms and small molecules
Open article →#232FUZKK selection 101–300
Aflofarm
Poland · European Union
Consumer healthFinished dosage forms and small molecules
Open article →#233FUZKK selection 101–300
USP Zdrowie
Poland · European Union
Consumer healthFinished dosage forms and small molecules
Open article →#234FUZKK selection 101–300
Selvita
Poland · European Union
API / CDMO / manufacturing
Open article →#235FUZKK selection 101–300
Meditop Pharmaceutical
Hungary · European Union
Finished dosage forms and small molecules
Open article →#236FUZKK selection 101–300
Béres Pharmaceuticals
Hungary · European Union
Consumer healthFinished dosage forms and small molecules
Open article →#237FUZKK selection 101–300
PannonPharma
Hungary · European Union
Finished dosage forms and small molecules
Open article →#238FUZKK selection 101–300
PRO.MED.CS Praha
Czechia · European Union
Finished dosage forms and small molecules
Open article →#239FUZKK selection 101–300
Contipro
Czechia · European Union
Diagnostics and contrast mediaFinished dosage forms and small molecules
Open article →#240FUZKK selection 101–300
SOTIO Biotech
Czechia · European Union
BiologicsOncology / ADC / high-potencyFinished dosage forms and small molecules
Open article →#241FUZKK selection 101–300
FAVEA
Czechia · European Union
Finished dosage forms and small molecules
Open article →#242FUZKK selection 101–300
Bioveta
Czechia · European Union
Veterinary pharmaFinished dosage forms and small molecules
Open article →#243FUZKK selection 101–300
Lek Pharmaceuticals
Slovenia · European Union
Finished dosage forms and small molecules
Open article →#244FUZKK selection 101–300
JAFRAL
Slovenia · European Union
API / CDMO / manufacturing
Open article →#245FUZKK selection 101–300
PLIVA Hrvatska
Croatia · European Union
Sterile and injectable productsFinished dosage forms and small molecules
Open article →#246FUZKK selection 101–300
JGL
Croatia · European Union
Sterile and injectable productsFinished dosage forms and small molecules
Open article →#247FUZKK selection 101–300
Belupo
Croatia · European Union
Finished dosage forms and small molecules
Open article →#248FUZKK selection 101–300
PharmaS
Croatia · European Union
Sterile and injectable productsFinished dosage forms and small molecules
Open article →#249FUZKK selection 101–300
Antibiotice Iași
Romania · European Union
Antibiotics and fermentationFinished dosage forms and small molecules
Open article →#250FUZKK selection 101–300
Terapia
Romania · European Union
Finished dosage forms and small molecules
Open article →#251FUZKK selection 101–300
Biofarm
Romania · European Union
BiologicsFinished dosage forms and small molecules
Open article →#252FUZKK selection 101–300
Zentiva Romania
Romania · European Union
Finished dosage forms and small molecules
Open article →#253FUZKK selection 101–300
Rompharm
Romania · European Union
Sterile and injectable productsFinished dosage forms and small molecules
Open article →#254FUZKK selection 101–300
Labormed Pharma
Romania · European Union
Finished dosage forms and small molecules
Open article →#255FUZKK selection 101–300
Sopharma
Bulgaria · European Union
Finished dosage forms and small molecules
Open article →#256FUZKK selection 101–300
Huvepharma
Bulgaria · European Union
Veterinary pharmaFinished dosage forms and small molecules
Open article →#257FUZKK selection 101–300
Biovet
Bulgaria · European Union
Veterinary pharmaFinished dosage forms and small molecules
Open article →#258FUZKK selection 101–300
Tchaikapharma High Quality Medicines
Bulgaria · European Union
Finished dosage forms and small molecules
Open article →#259FUZKK selection 101–300
Unipharm Bulgaria
Bulgaria · European Union
Finished dosage forms and small molecules
Open article →#260FUZKK selection 101–300
ELPEN Pharmaceuticals
Greece · European Union
Finished dosage forms and small molecules
Open article →#261FUZKK selection 101–300
Vianex
Greece · European Union
Finished dosage forms and small molecules
Open article →#262FUZKK selection 101–300
Rafarm
Greece · European Union
Sterile and injectable productsFinished dosage forms and small molecules
Open article →#263FUZKK selection 101–300
Uni-Pharma
Greece · European Union
Finished dosage forms and small molecules
Open article →#264FUZKK selection 101–300
Genepharm
Greece · European Union
BiologicsFinished dosage forms and small molecules
Open article →#265FUZKK selection 101–300
PharOS
Greece · European Union
Finished dosage forms and small molecules
Open article →#266FUZKK selection 101–300
Famar
Greece · European Union
Sterile and injectable productsFinished dosage forms and small molecules
Open article →#267FUZKK selection 101–300
Tecnimede
Portugal · European Union
Finished dosage forms and small molecules
Open article →#268FUZKK selection 101–300
Bluepharma
Portugal · European Union
Finished dosage forms and small molecules
Open article →#269FUZKK selection 101–300
Generis
Portugal · European Union
BiologicsFinished dosage forms and small molecules
Open article →#270FUZKK selection 101–300
Medinfar
Portugal · European Union
Finished dosage forms and small molecules
Open article →#271FUZKK selection 101–300
Laboratórios Azevedos
Portugal · European Union
Finished dosage forms and small molecules
Open article →#272FUZKK selection 101–300
Sidefarma
Portugal · European Union
Finished dosage forms and small molecules
Open article →#273FUZKK selection 101–300
Marinomed Biotech
Austria · European Union
BiologicsFinished dosage forms and small molecules
Open article →#274FUZKK selection 101–300
Kwizda Pharma
Austria · European Union
Finished dosage forms and small molecules
Open article →#275FUZKK selection 101–300
Montavit
Austria · European Union
Finished dosage forms and small molecules
Open article →#276FUZKK selection 101–300
Polymun Scientific
Austria · European Union
API / CDMO / manufacturing
Open article →#277FUZKK selection 101–300
EVER Pharma
Austria · European Union
Sterile and injectable productsFinished dosage forms and small molecules
Open article →#278FUZKK selection 101–300
G.L. Pharma
Austria · European Union
Finished dosage forms and small molecules
Open article →#279FUZKK selection 101–300
Sigmapharm Arzneimittel
Austria · European Union
Finished dosage forms and small molecules
Open article →#280FUZKK selection 101–300
Fermion
Finland · European Union
API / CDMO / manufacturing
Open article →#281FUZKK selection 101–300
Biovian
Finland · European Union
API / CDMO / manufacturingBiologics
Open article →#282FUZKK selection 101–300
DelSiTech
Finland · European Union
Finished dosage forms and small molecules
Open article →#283FUZKK selection 101–300
Nanoform
Finland · European Union
Finished dosage forms and small molecules
Open article →#284FUZKK selection 101–300
Faron Pharmaceuticals
Finland · European Union
Finished dosage forms and small molecules
Open article →#285FUZKK selection 101–300
Grindeks
Latvia · European Union
Finished dosage forms and small molecules
Open article →#286FUZKK selection 101–300
Olpha
Latvia · European Union
Finished dosage forms and small molecules
Open article →#287FUZKK selection 101–300
PharmIdea
Latvia · European Union
Finished dosage forms and small molecules
Open article →#288FUZKK selection 101–300
Northway Biotech
Lithuania · European Union
API / CDMO / manufacturing
Open article →#289FUZKK selection 101–300
Valentis
Lithuania · European Union
Consumer healthFinished dosage forms and small molecules
Open article →#290FUZKK selection 101–300
Aconitum
Lithuania · European Union
Consumer healthFinished dosage forms and small molecules
Open article →#291FUZKK selection 101–300
Icosagen
Estonia · European Union
Cell and gene therapyFinished dosage forms and small molecules
Open article →#292FUZKK selection 101–300
TBD-Biodiscovery
Estonia · European Union
Diagnostics and contrast mediaFinished dosage forms and small molecules
Open article →#293FUZKK selection 101–300
Medochemie
Cyprus · European Union
Sterile and injectable productsFinished dosage forms and small molecules
Open article →#294FUZKK selection 101–300
Remedica
Cyprus · European Union
Sterile and injectable productsFinished dosage forms and small molecules
Open article →#295FUZKK selection 101–300
Delorbis Pharmaceuticals
Cyprus · European Union
Finished dosage forms and small molecules
Open article →#296FUZKK selection 101–300
Aurobindo Pharma Malta
Malta · European Union
API / CDMO / manufacturing
Open article →#297FUZKK selection 101–300
Saneca Pharmaceuticals
Slovakia · European Union
Sterile and injectable productsFinished dosage forms and small molecules
Open article →#298FUZKK selection 101–300
Imuna Pharm
Slovakia · European Union
Vaccines and plasma productsFinished dosage forms and small molecules
Open article →#299FUZKK selection 101–300
Biotika
Slovakia · European Union
Antibiotics and fermentationFinished dosage forms and small molecules
Open article →#300FUZKK selection 101–300
C² Pharma
Luxembourg · European Union
API / CDMO / manufacturing
Open article →—